Literature DB >> 15331514

Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia.

Alexandre Hertig, Nadia Berkane, Guillaume Lefevre, Karine Toumi, Hans-Peter Marti, Jacqueline Capeau, Serge Uzan, Eric Rondeau.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15331514     DOI： 10.1373/clinchem.2004.036715

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  41 in total

1.  Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice.

Authors:  Ashley K Woods; Darren S Hoffmann; Christine J Weydert; Scott D Butler; Yi Zhou; Ram V Sharma; Robin L Davisson
Journal:  Hypertension       Date:  2010-11-15       Impact factor: 10.190

Review 2.  Anti-angiogenesis and Preeclampsia in 2016.

Authors:  Susanne Schrey-Petersen; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

3.  Study of the molecular variation in pre-eclampsia placenta based on micro-Raman spectroscopy.

Authors:  Si-Jin Chen; Yuan Zhang; Xiang-Ping Ye; Kun Hu; Mei-Fang Zhu; Yan-Yue Huang; Mei Zhong; Zheng-Fei Zhuang
Journal:  Arch Gynecol Obstet       Date:  2014-05-28       Impact factor: 2.344

Review 4.  A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.

Authors:  Sayuri Padayachee; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2019-07-24       Impact factor: 5.369

5.  Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips.

Authors:  Te-Yao Hsu; Jyun-Mu Lin; Mai-Huong T Nguyen; Feng-Hsiang Chung; Ching-Chang Tsai; Hsin-Hsin Cheng; Yun-Ju Lai; Hsuan-Ning Hung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2017-12-28       Impact factor: 5.911

Review 6.  Prediction of preeclampsia-bench to bedside.

Authors:  Anjali Acharya; Wunnie Brima; Shivakanth Burugu; Tanvi Rege
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

7.  A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Samuel S Edwin; Ricardo Gomez; Lami Yeo; Agustin Conde-Agudelo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

Review 8.  Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia.

Authors:  Hernan D Kopcow; S Ananth Karumanchi
Journal:  J Reprod Immunol       Date:  2007-05-09       Impact factor: 4.054

9.  The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.

Authors:  Tinnakorn Chaiworapongsa; Jimmy Espinoza; Francesca Gotsch; Yeon Mee Kim; Gi Jin Kim; Luis F Goncalves; Samuel Edwin; Juan Pedro Kusanovic; Offer Erez; Nandor Gabor Than; Sonia S Hassan; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01

10.  Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Francesca Gotsch; Jimmy Espinoza; Jyh Kae Nien; Luis Goncalves; Samuel Edwin; Yeon Mee Kim; Offer Erez; Juan Pedro Kusanovic; Beth L Pineles; Zoltan Papp; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.